NFGH
KURA icon

Nan Fung Group Holdings’s Kura Oncology KURA Stock Holding History

Nan Fung Group Holdings’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-11,650
Closed -$163K – 50
2021
Q4 		$163K Buy
+11,650
New +$189K 0.05% 52

Other funds holding KURA

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
AWA
Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Nan Fung Group Holdings's KURA Position: Q1 2022 in Review

Nan Fung Group Holdings sold out of Kura Oncology (KURA) in Q1 2022, closing a stake of 11,650 shares — an estimated $163K sold.

Nan Fung Group Holdings first reported a position in KURA in Q4 2021 and held it in 1 quarter. The position peaked at $163K in Q4 2021. 152 funds tracked by Wall St. Rank hold KURA as of Q1 2022.

  • Nan Fung Group Holdings reported no remaining Kura Oncology position as of Q1 2022 after selling out during the quarter.
  • Nan Fung Group Holdings sold 11,650 Kura Oncology shares in Q1 2022, an estimated $163K.
  • Nan Fung Group Holdings first reported a position in Kura Oncology in Q4 2021 and held it in 1 quarter.
  • Nan Fung Group Holdings's Kura Oncology position peaked at $163K in Q4 2021.
  • 152 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2022.

Based on Nan Fung Group Holdings's 13F filing for Q1 2022, filed 13 May 2022.